Phillip S. Low,Francesco Turrini,Antonella Pantaleo
申请号：
US15566590
公开号：
US20180078552A1
申请日:
2016.04.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure generally relates to methods of treating hemolytic diseases such as sickle cell anemia using kinase inhibitors, for example, compounds that inhibit the spleen tyrosine kinase (SYK). In some embodiments a method is presented to prevent thrombosis in blood vessels of patients with a hemolytic disease comprising the step of: administrating to a patient having at least one hemolytic disease a therapeutically effective amount of at least one SYK inhibitor. In some embodiments the method includes repeatedly administering the SYK kinase inhibitor to a patient.
